T. Rowe Price Associates
BNGO icon

T. Rowe Price Associates’s Bionano Genomics BNGO Stock Holding History

T. Rowe Price Associates’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,173
Closed -$20K – 3045
2024
Q4 		$20K Hold
1,173
– – ﹤0.01% 2993
2024
Q3 		$32K Hold
1,173
– – ﹤0.01% 2968
2024
Q2 		$48K Hold
1,173
– – ﹤0.01% 2860
2024
Q1 		$79K Buy
1,173
+648
+123% +$48.4K ﹤0.01% 2817
2023
Q4 		$60K Buy
525
+342
+187% +$35.7K ﹤0.01% 2778
2023
Q3 		$34K Buy
183
+88
+93% +$23.1K ﹤0.01% 2819
2023
Q2 		$35K Sell
95
-92
-49% -$41.5K ﹤0.01% 2839
2023
Q1 		$125K Buy
187
+7
+4% +$6.22K ﹤0.01% 2639
2022
Q4 		$158K Buy
180
+10
+6% +$12.6K ﹤0.01% 2606
2022
Q3 		$187K Buy
170
+29
+21% +$38.3K ﹤0.01% 2568
2022
Q2 		$116K Buy
141
+3
+2% +$3.09K ﹤0.01% 2729
2022
Q1 		$214K Buy
138
+10
+8% +$13.5K ﹤0.01% 2689
2021
Q4 		$229K Sell
128
-43
-25% -$115K ﹤0.01% 2707
2021
Q3 		$563K Buy
171
+45
+36% +$157K ﹤0.01% 2328
2021
Q2 		$553K Buy
126
+41
+48% +$162K ﹤0.01% 2346
2021
Q1 		$414K Buy
+85
New +$479K ﹤0.01% 2453

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

T. Rowe Price Associates's BNGO Position: Q1 2025 in Review

T. Rowe Price Associates sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 1,173 shares — an estimated $20K sold.

T. Rowe Price Associates first reported a position in BNGO in Q1 2021 and held it in 16 quarters. The position peaked at $563K in Q3 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • T. Rowe Price Associates reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,173 Bionano Genomics shares in Q1 2025, an estimated $20K.
  • T. Rowe Price Associates first reported a position in Bionano Genomics in Q1 2021 and held it in 16 quarters.
  • T. Rowe Price Associates's Bionano Genomics position peaked at $563K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.